BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19155317)

  • 1. Retinoic acid receptor and retinoid X receptor subtype expression for the differential diagnosis of thyroid neoplasms.
    Hoftijzer HC; Liu YY; Morreau H; van Wezel T; Pereira AM; Corssmit EP; Romijn JA; Smit JW
    Eur J Endocrinol; 2009 Apr; 160(4):631-8. PubMed ID: 19155317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
    Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
    Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA expression pattern of retinoic acid and retinoid X nuclear receptor subtypes in human thyroid papillary carcinoma.
    Macejová D; Galbavý S; Podoba J; Bialešová L; Brtko J
    Oncol Rep; 2013 Nov; 30(5):2371-8. PubMed ID: 23969901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid acid receptor expression is helpful to distinguish between adenoma and well-differentiated carcinoma in the thyroid.
    Gauchotte G; Lacomme S; Brochin L; Tournier B; Cahn V; Monhoven N; Piard F; Klein M; Martinet N; Rochette-Egly C; Vignaud JM
    Virchows Arch; 2013 Jun; 462(6):619-32. PubMed ID: 23639973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of retinoid X receptor isoforms in human thyroid carcinomas.
    Takiyama Y; Miyokawa N; Sugawara A; Kato S; Ito K; Sato K; Oikawa K; Kobayashi H; Kimura S; Tateno M
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5851-61. PubMed ID: 15531552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
    Simms A; Jacob RP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules.
    Finley DJ; Arora N; Zhu B; Gallagher L; Fahey TJ
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3214-23. PubMed ID: 15240595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of microarray expression profiles between follicular variant of papillary thyroid carcinomas and follicular adenomas of the thyroid.
    Schulten HJ; Al-Mansouri Z; Baghallab I; Bagatian N; Subhi O; Karim S; Al-Aradati H; Al-Mutawa A; Johary A; Meccawy AA; Al-Ghamdi K; Al-Hamour O; Al-Qahtani MH; Al-Maghrabi J
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S7. PubMed ID: 25923053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
    Haugen BR; Larson LL; Pugazhenthi U; Hays WR; Klopper JP; Kramer CA; Sharma V
    J Clin Endocrinol Metab; 2004 Jan; 89(1):272-80. PubMed ID: 14715861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization.
    Jiang SY; Shen SR; Shyu RY; Yu JC; Harn HJ; Yeh MY; Lee MM; Chang YC
    Br J Cancer; 1999 Apr; 80(1-2):206-14. PubMed ID: 10389997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of retinoic acid receptor beta protein (RAR beta) in human papillary thyroid carcinoma: immunohistochemical and western blot study.
    Rochaix P; Monteil-Onteniente S; Rochette-Egly C; Caratero C; Voigt JJ; Jozan S
    Histopathology; 1998 Oct; 33(4):337-43. PubMed ID: 9822923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of retinoid receptors in sebaceous cell carcinoma.
    Chakravarti N; El-Naggar AK; Lotan R; Anderson J; Diwan AH; Saadati HG; Diba R; Prieto VG; Esmaeli B
    J Cutan Pathol; 2006 Jan; 33(1):10-7. PubMed ID: 16441406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions.
    Martinet N; Alla F; Farré G; Labib T; Drouot H; Vidili R; Picard E; Gaube MP; Le Faou D; Siat J; Borelly J; Vermylen P; Bazarbachi T; Vignaud JM; Martinet Y
    Cancer Res; 2000 Jun; 60(11):2869-75. PubMed ID: 10850430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study.
    Prasad ML; Pellegata NS; Kloos RT; Barbacioru C; Huang Y; de la Chapelle A
    Thyroid; 2004 Mar; 14(3):169-75. PubMed ID: 15072698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial membrane antigen and S-100 protein expression in benign and malignant papillary thyroid neoplasms.
    Kilicarslan B; Pesterelli EH; Oren N; Sargin FC; Karpuzoglu G
    Adv Clin Path; 2000 Oct; 4(4):155-8. PubMed ID: 11436147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.